Last reviewed · How we verify
NCT04324008
Clinical Comparison of Different Flowable Resin Composites
NA trial testing Constic in Tooth Diseases in 28 participants. Participants enrolled and being followed up; not accepting new ones.
1 January 2018
Quick facts
| Lead sponsor | Hacettepe University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 28 |
| Start date | 1 November 2017 |
| Primary completion | 1 January 2018 |
| Estimated completion | 1 November 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Constic
- G-ænial Universal Flo
- Tetric N-Flow (self-etch)
- Tetric N-Flow (etch&rinse)
Conditions studied
- Tooth Diseases — all drugs for Tooth Diseases →
Sponsor
Hacettepe University
Who can join
Adults 18 to 65, any sex, with Tooth Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate a self-adhesive flowable resin composite, a flowable resin composite with high viscosity and a conventional flowable resin composite in combination with a universal adhesive using two different application modes. All patients will receive at least 4 occlusal restorations. Cavities will be divided into four groups according to restorative systems used: Constic (a self-adhering flowable composite), G-ænial Universal Flo (a highly filled flowable composite), Tetric N-Flow (self-etch) (a conventional flowable composite), Tetrin N-Flow (etch\&rinse).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04324008
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tooth Diseases
Currently open trials in the same condition.
- NCT07393997 — Autogenous Tooth Transplantation With Instrumentally Simulated Open Apex and Platelet-Rich Fibrin · NA · recruiting
- NCT06375837 — Comparative Evaluation of an Alkasite-based Restorative Material and Two Different Resin Composites · NA · active not recruiting
- NCT03415412 — Clinical Evaluation of Three Different Universal Adhesives in Non-carious Cervical Lesions · NA · active not recruiting
- NCT01805869 — Oral Specimen and Data Acquisition Study of Subjects Requiring Third Molar Removal · recruiting
Other Hacettepe University trials
Trials by the same sponsor.
- NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
- NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
- NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
- NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
- NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04324008 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
- Last refreshed: 3 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04324008.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing